Cargando…

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Resting state functional connectivity (rs-fMRI) is impaired early in persons who subsequently develop Alzheimer’s disease (AD) dementia. This impairment may be leveraged to aid investigation of the pre-clinical phase of AD. We developed a model that predicts brain age from resting state (rs)-fMRI da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonneaud, Julie, Baria, Alex T., Pichet Binette, Alexa, Gordon, Brian A., Chhatwal, Jasmeer P., Cruchaga, Carlos, Jucker, Mathias, Levin, Johannes, Salloway, Stephen, Farlow, Martin, Gauthier, Serge, Benzinger, Tammie L. S., Morris, John C., Bateman, Randall J., Breitner, John C. S., Poirier, Judes, Vachon-Presseau, Etienne, Villeneuve, Sylvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429427/ https://www.ncbi.nlm.nih.gov/pubmed/34504080 http://dx.doi.org/10.1038/s41467-021-25492-9

Ejemplares similares

Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2021)

Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease
por: Vogel, Jacob W, et al.
Publicado: (2018)

Tau accumulation and its spatial progression across the Alzheimer’s disease spectrum
por: St-Onge, Frédéric, et al.
Publicado: (2023)

Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer’s Disease
por: Strikwerda-Brown, Cherie, et al.
Publicado: (2022)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Functional connectome fingerprinting across the lifespan
por: St-Onge, Frédéric, et al.
Publicado: (2023)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s disease
por: Salvadó, Gemma, et al.
Publicado: (2023)

Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease
por: Tremblay-Mercier, Jennifer, et al.
Publicado: (2021)

Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network
por: Karch, Celeste M., et al.
Publicado: (2018)

Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease
por: Schoemaker, Dorothee, et al.
Publicado: (2015)

No apparent effect of naproxen on CSF markers of innate immune activation
por: Meyer, Pierre‐François, et al.
Publicado: (2019)

Familiarity deficits in cognitively normal aging individuals with APOE ε4: A follow-up investigation of medial temporal lobe structural correlates
por: Schoemaker, Dorothee, et al.
Publicado: (2017)

Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
por: Picard, Cynthia, et al.
Publicado: (2021)

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease
por: Chen, Hsiang-Han, et al.
Publicado: (2022)

Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways
por: Elbert, Donald L., et al.
Publicado: (2022)

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
por: Johnson, Erik C. B., et al.
Publicado: (2023)

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
por: Millar, Peter R, et al.
Publicado: (2023)

An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations
por: Dube, Umber, et al.
Publicado: (2019)

Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
por: Dobrowolska, Justyna A., et al.
Publicado: (2014)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
por: Müller, Stephan, et al.
Publicado: (2017)

Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer’s Disease
por: Konishi, Kyoko, et al.
Publicado: (2018)

Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype
por: Li, Huifangjie, et al.
Publicado: (2020)

Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease
por: Tuwaig, Miranda, et al.
Publicado: (2017)

Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis
por: Meyer, Pierre-François, et al.
Publicado: (2018)

Odor identification as a biomarker of preclinical AD in older adults at risk
por: Lafaille-Magnan, Marie-Elyse, et al.
Publicado: (2017)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
por: Araque Caballero, Miguel Ángel, et al.
Publicado: (2018)

Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
por: Joseph‐Mathurin, Nelly, et al.
Publicado: (2022)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease
por: Vermunt, Lisa, et al.
Publicado: (2020)

Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2023)

Hippocampal morphology mediates biased memories of chronic pain
por: Berger, Sara E., et al.
Publicado: (2017)

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer’s disease brains
por: Novotny, Brenna C., et al.
Publicado: (2023)

BDNF Val(66)Met Polymorphism Influences Visuomotor Associative Learning and the Sensitivity to Action Observation
por: Taschereau-Dumouchel, Vincent, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aibae1gp8klsgcuq07ile1vn10